# $bntx BioNTech's multi-modality approach is gaining traction, outperforming Moderna's pipeline, while concerns linger over Daiichi Sankyo's Claudin-6 therapy. ### About $bntx $BNTX is a biotechnology company focused on developing innovative therapies. ### Engagements: [-----] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$bntx/time-series/interactions.tsv) Current Value: [-----] Daily Average: [------] [--] Week: [--] -100% [--] Month: [-------] -14% [--] Months: [---------] -71% [--] Year: [---------] +4.50% 1-Year High: [-------] on 2025-03-12 1-Year Low: [---] on 2026-02-08 Engagements by network (24h): X: [-----] Reddit: [--] ### Mentions: [--] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$bntx/time-series/posts_active.tsv) Current Value: [--] Daily Average: [---] [--] Month: [---] +293% 1-Year High: [---] on 2026-01-10 1-Year Low: [--] on 2025-12-07 Mentions by network (24h): X: [--] Reddit: [--] ### Creators: [--] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$bntx/time-series/contributors_active.tsv) [--] unique social accounts have posts mentioning $bntx in the last [--] hours which is down 53% from [---] in the previous [--] hours Daily Average: [--] [--] Month: [---] +265% 1-Year High: [---] on 2025-06-28 1-Year Low: [--] on 2025-12-07 The most influential creators that mention $bntx in the last [--] hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@anita37992698](/creator/twitter/anita37992698) | [--] | [---] | [--] | [--] | | [@LuxOpesResearch](/creator/twitter/LuxOpesResearch) | [--] | [-----] | [--] | [--] | | [@JacobPlieth](/creator/twitter/JacobPlieth) | [--] | [------] | [--] | [--] | [View More](/list/creators/$bntx/100) ### Top $bntx Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "$DSNKY $BNTX Dark clouds for Daiichi in Claudin6 https://www.oncologypipeline.com/apexonco/dark-clouds-daiichi-claudin6 https://www.oncologypipeline.com/apexonco/dark-clouds-daiichi-claudin6" [X Link](https://x.com/MarcJacksonLA/status/2018708410842185815) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2026-02-03T15:29Z [----] followers, [---] engagements "$BNTX $MRNA BioNTechs Multi-Modality Play Outpaces Modernas mRNA-Focused Pipeline https://www.biospace.com/business/biontechs-multi-modality-play-outpaces-modernas-mrna-focused-pipeline https://www.biospace.com/business/biontechs-multi-modality-play-outpaces-modernas-mrna-focused-pipeline" [X Link](https://x.com/MarcJacksonLA/status/2018705223976439949) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2026-02-03T15:16Z [----] followers, [---] engagements "@ACapitalLP I don't get why people go long $MRNA given admin headwinds and even then why not go long a better company like $BNTX" [X Link](https://x.com/TidefallCapital/status/2018406057437995431) [@TidefallCapital](/creator/x/TidefallCapital) 2026-02-02T19:27Z 39.3K followers, [----] engagements "🚨 Pre-market buzz $AQST $CRML $U $TWST $USAR $ORCL $UAMY $UUUU $PSNY $NB $MP $TMQ $RVTY $PLTR $ADSK $BMNR $SBET $MSTR $CLSK $MARA $HOOD $RIOT $GLXY $SATS $COIN $IREN $BITF $BNTX $TSLA $DIS $NVDA" [X Link](https://x.com/AIStockSavvy/status/2018312831985140036) [@AIStockSavvy](/creator/x/AIStockSavvy) 2026-02-02T13:17Z 27.2K followers, [----] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
BioNTech's multi-modality approach is gaining traction, outperforming Moderna's pipeline, while concerns linger over Daiichi Sankyo's Claudin-6 therapy.
$BNTX is a biotechnology company focused on developing innovative therapies.
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [--] -100%
[--] Month: [-------] -14%
[--] Months: [---------] -71%
[--] Year: [---------] +4.50%
1-Year High: [-------] on 2025-03-12
1-Year Low: [---] on 2026-02-08
Engagements by network (24h): X: [-----] Reddit: [--]
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [---]
[--] Month: [---] +293%
1-Year High: [---] on 2026-01-10
1-Year Low: [--] on 2025-12-07
Mentions by network (24h): X: [--] Reddit: [--]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $bntx in the last [--] hours which is down 53% from [---] in the previous [--] hours
Daily Average: [--]
[--] Month: [---] +265%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-12-07
The most influential creators that mention $bntx in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @anita37992698 | [--] | [---] | [--] | [--] |
| @LuxOpesResearch | [--] | [-----] | [--] | [--] |
| @JacobPlieth | [--] | [------] | [--] | [--] |
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$DSNKY $BNTX Dark clouds for Daiichi in Claudin6 https://www.oncologypipeline.com/apexonco/dark-clouds-daiichi-claudin6 https://www.oncologypipeline.com/apexonco/dark-clouds-daiichi-claudin6"
X Link @MarcJacksonLA 2026-02-03T15:29Z [----] followers, [---] engagements
"$BNTX $MRNA BioNTechs Multi-Modality Play Outpaces Modernas mRNA-Focused Pipeline https://www.biospace.com/business/biontechs-multi-modality-play-outpaces-modernas-mrna-focused-pipeline https://www.biospace.com/business/biontechs-multi-modality-play-outpaces-modernas-mrna-focused-pipeline"
X Link @MarcJacksonLA 2026-02-03T15:16Z [----] followers, [---] engagements
"@ACapitalLP I don't get why people go long $MRNA given admin headwinds and even then why not go long a better company like $BNTX"
X Link @TidefallCapital 2026-02-02T19:27Z 39.3K followers, [----] engagements
"🚨 Pre-market buzz $AQST $CRML $U $TWST $USAR $ORCL $UAMY $UUUU $PSNY $NB $MP $TMQ $RVTY $PLTR $ADSK $BMNR $SBET $MSTR $CLSK $MARA $HOOD $RIOT $GLXY $SATS $COIN $IREN $BITF $BNTX $TSLA $DIS $NVDA"
X Link @AIStockSavvy 2026-02-02T13:17Z 27.2K followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$bntx